0.00
180 Life Sciences Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
See More
Previous Close:
$7.04
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
$-3.12M
P/E Ratio:
0.00
EPS:
-4.8149
Net Cash Flow:
$-2.69M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
Compare ATNF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ATNF
180 Life Sciences Corp
|
0.00 | 1.08B | 0 | -3.12M | -2.69M | -4.8149 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
How 180 Life Sciences Corp. Equity Warrant stock reacts to Fed rate cutsJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
How to monitor 180 Life Sciences Corp. with trend dashboardsJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Pattern recognition hints at 180 Life Sciences Corp. Equity Warrant upsideMarket Performance Recap & Fast Exit and Entry Strategy Plans - newser.com
Trend analysis for 180 Life Sciences Corp. Equity Warrant this weekJuly 2025 Reactions & Verified Swing Trading Watchlist - newser.com
Is this a good reentry point in 180 Life Sciences Corp.2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Visual trend scoring systems applied to 180 Life Sciences Corp.2025 Support & Resistance & High Yield Stock Recommendations - newser.com
Custom watchlist performance reports with 180 Life Sciences Corp.July 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
What dividend safety score for 180 Life Sciences Corp. stockMarket Trend Review & Free Daily Entry Point Trade Alerts - newser.com
How 180 Life Sciences Corp. stock performs in rate cut cyclesGDP Growth & Weekly Market Pulse Updates - newser.com
Why 180 Life Sciences Corp. Equity Warrant stock could outperform in 2025July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Is 180 Life Sciences Corp. stock overvalued by current metricsShare Buyback & Technical Entry and Exit Tips - newser.com
Institutional scanner results for 180 Life Sciences Corp. Equity WarrantWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
Can volume confirm reversal in 180 Life Sciences Corp. Equity WarrantBear Alert & Daily Stock Trend Watchlist - newser.com
How to integrate 180 Life Sciences Corp. into portfolio analysis toolsWeekly Trend Report & Proven Capital Preservation Tips - newser.com
How resilient is 180 Life Sciences Corp. stock in market downturns2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - newser.com
Custom strategy builders for tracking 180 Life Sciences Corp. Equity WarrantEarnings Risk Summary & Reliable Trade Execution Plans - newser.com
Short interest data insights for 180 Life Sciences Corp.2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Is 180 Life Sciences Corp. stock a bargain at current levelsMarket Risk Analysis & Verified High Yield Trade Plans - newser.com
Will 180 Life Sciences Corp. stock remain a Wall Street favorite2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Leading vs lagging indicators on 180 Life Sciences Corp. Equity Warrant performanceShort Setup & Accurate Technical Buy Alerts - newser.com
Published on: 2025-11-15 13:08:49 - newser.com
What valuation multiples suggest for 180 Life Sciences Corp. Equity Warrant stock2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Understanding 180 Life Sciences Corp.’s price movementEarnings Trend Report & Weekly Return Optimization Alerts - newser.com
Published on: 2025-11-15 07:26:07 - newser.com
Can you recover from losses in 180 Life Sciences Corp.Market Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Will 180 Life Sciences Corp. stock go up soonEarnings Trend Report & Safe Capital Allocation Plans - newser.com
Does 180 Life Sciences Corp. Equity Warrant show high probability of reboundEarnings Overview Report & Consistent Return Strategy Ideas - newser.com
Can 180 Life Sciences Corp. hit a new high this monthWeekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com
180 Life Sciences Corp. stock retracement – recovery analysisVolume Spike & Daily Momentum Trading Reports - newser.com
180 Life Sciences Corp. Equity Warrant stock prediction for this weekJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Real time scanner hits for 180 Life Sciences Corp. explained2025 Market Sentiment & Short-Term High Return Ideas - newser.com
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):